ANSTO's unique capabilities and expertise in the production and application of radiotracers for imaging have been highlighted in a recent publication in the journal Theranostics. In collaboration with researchers from the Children's Cancer Institute (CCI) in Sydney, imaging was pivotal in understanding the mechanism of a promising new treatment developed at CCI for the childhood cancer neuroblastoma
In vivo evaluations of a gonadotropin-releasing hormone-receptor single photon emission computed tomography radiotracer for non-invasive detection of gonadotropin-releasing hormone-receptors in brain
The present study aims to analyze the characteristics of F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) for cerebral alveolar echinococcosis (CAE)
The purpose of this study was to investigate the association between the tumor uptake of these 2 tracers in invasive ductal carcinoma and to examine the correlation of uptake of each tracer with prognostic factors and tumor molecular subtypes
An association between immune-related adverse events (irAEs) caused by immunotherapeutic agents and the clinical benefit of immunotherapy has been suggested. We retrospectively evaluated by means of 18 F-FDG PET / CT lymphoid tissue changes in the mediastinal/hilar lymph nodes and the spleen in response to ipilimumab administration in metastatic melanoma
Investigators at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) have used magnetoencephalography (MEG) – a technology that measures brain activity by detecting the weak magnetic fields produced by the brain's normal electrical currents – to measure levels of the iron-based mineral called magnetite in the human brain
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Researchers at University Putra Malaysia found a relationship between some markers of inflammation in the body and the aggressiveness of certain malignant tumors
For the accurate use of the different treatment options, you need imaging techniques are necessary to reduce side effects of the aggressive therapies but also to avoid undertreatment exposing the patient to the risk of recurrence
EXPLORER, the world's first medical imaging scanner that can capture a 3-D picture of the whole human body at once, has produced its first scans, exhibited in the study
This study aimed to develop a PET imaging agent of angiomotin (AMOT) expression, a potential biomarker of functional tissue regeneration in post-ischaemic conditions
When patients with dependence on alcohol, cocaine or nicotine are shown drug cues, or images related to the substance, an area of their brain known as the medial prefrontal cortex (mPFC) shows increased activity, report investigators at the Medical University of South Carolina ( MUSC) in an article published online September 7, 2018, in Translational Psychiatry